Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2013-09-16 to 2022-09-30
Current total value of award: $47755722.77
Description: DUE TO CHANGES IN THE OVERHEAD A COST OVERRUN TRANSPIRED. TO CLOSE OUT THIS CONTRACT FUNDS ARE BEING ADDED TO PAY THE OBLIGATION. TOTAL AMOUNT OF CONTRACT IS 47,755,722.77.